Paid Clinical Trials in Beavercreek, OH
As of July 2026, 30 paid clinical trials are recruiting in Beavercreek, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Beavercreek offers studies at sites including Indu and Raj Soin Medical Center for conditions such as Anatomic Stage IV Breast Cancer AJCC v8, Hypertension, Melanoma, Metastatic Malignant Neoplasm in the Brain. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Beavercreek
Trials by drug in Beavercreek
Filter results
29 clinical trials
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
E-Mindfulness Approaches for Living After Breast Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Top Research Study Locations in Beavercreek
Researchers run research studies in Beavercreek, OH at 13 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Indu and Raj Soin Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Melanoma, Metastatic Malignant Neoplasm in the Brain | 16 |
| Dayton Gastroenterology, Inc. | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Clinical Inquest Center | Moderately to Severely Active Crohns Disease | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Dayton Gastroenterology - Beavercreek | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| Feet First Institute of Beavercreek | Diabetic Foot Ulcer, Pressure Ulcer, Soft Tissue Reinforcement | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Research Innovations, LLC | Acute Severe Hypertension, Hypertension, Hypertensive Emergency | 1 |
| Research Innovations, LLC | Coronavirus Disease (COVID-19) | 1 |
| Research | Hypertriglyceridemia | 1 |
| Wright State Physicians Health Center | NonSegmental Vitiligo | 1 |
| Xencor Investigative Site | Ulcerative Colitis (UC) | 1 |
Active & Upcoming Studies in Beavercreek (2026)
Recruiting trials in Beavercreek grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (15 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics · Wake Forest University Health Sciences
Cardiovascular (4 active studies)
- Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension · Phase 2 · Kardigan, Inc.
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Beavercreek
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Hypertension (2 active studies)
- Melanoma (2 active studies)
- Metastatic Malignant Neoplasm in the Brain (2 active studies)
- Metastatic Melanoma (2 active studies)
- Metastatic Renal Cell Carcinoma (2 active studies)
Leading research sponsors in Beavercreek
- SWOG Cancer Research Network
- NRG Oncology
- Hoffmann-La Roche
- ECOG-ACRIN Cancer Research Group
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Beavercreek?
There are approximately 30 recruiting clinical trials in Beavercreek, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Beavercreek pay participants?
Most recruiting trials in Beavercreek compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Beavercreek?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Beavercreek?
The most common conditions under active study in Beavercreek include Anatomic Stage IV Breast Cancer AJCC v8 (2), Hypertension (2), Melanoma (2), Metastatic Malignant Neoplasm in the Brain (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Beavercreek?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Beavercreek on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Beavercreek?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Beavercreek?
Recruiting research sites in Beavercreek include Indu and Raj Soin Medical Center, Dayton Gastroenterology, Inc., Anthos Investigative, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Beavercreek right now?
The largest active categories in Beavercreek are Cancer & tumors (15), Cardiovascular (4), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.